Innate immune activation by checkpoint inhibition in human patient-derived lung cancer tissues
Although Pembrolizumab-based immunotherapy has significantly improved lung cancer patient survival, many patients show variable efficacy and resistance development. A better understanding of the drug’s action is needed to improve patient outcomes. Functional heterogeneity of the tumor microenvironme...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
eLife Sciences Publications Ltd
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/6541a0fc470f4f33989f246beecdeb72 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|